📄 test.txt
字号:
well RB O. . OConceivably RB O, , Oin IN Oa DT B-NPscaled-back JJ I-NPbuy-out NN I-NP, , Othey PRP B-NPcould MD Obe VB Obumped VBN Oback RB Oto TO Ocoach NN B-NPseats NNS I-NPfor IN Olife NN B-NP. . OThomas NNP B-NPH. NNP I-NPJohnson NNP I-NP, , Opresident NN B-NPof IN Othe DT B-NPCoatedboard NNP I-NPdivision NN I-NPof IN OMead NNP B-NPCorp. NNP I-NP, , Owas VBD Onamed VBN Opresident NN B-NPof IN OManville NNP B-NPForest NNP I-NPProducts NNP I-NPCorp. NNP I-NP, , Oa DT B-NPManville NNP I-NPunit NN I-NP, , Oand CC Osenior JJ B-NPvice NN I-NPpresident NN I-NPof IN OManville NNP B-NPCorp NNP I-NP. . OMr. NNP B-NPJohnson NNP I-NPsucceeds VBZ OHarry NNP B-NPW. NNP I-NPSherman NNP I-NP, , Owho WP B-NPresigned VBD Oto TO Opursue VB Oother JJ B-NPinterests NNS I-NP, , Oin IN Oboth DT B-NPpositions NNS I-NP. . OManville NNP B-NPis VBZ Oa DT B-NPbuilding NN I-NPand CC I-NPforest NN I-NPproducts NNS I-NPconcern VBP I-NP. . OUS PRP B-NPFacilities NNP I-NPCorp. NNP I-NPsaid VBD ORobert NNP B-NPJ. NNP I-NPPercival NNP I-NPagreed VBD Oto TO Ostep VB Odown RB Oas IN Ovice NN B-NPchairman NN I-NPof IN Othe DT B-NPinsurance NN I-NPholding VBG I-NPcompany NN I-NP. . O`` `` OThere EX B-NPwas VBD Oa DT B-NPdifference NN I-NPof IN Oopinion NN B-NPas IN Oto TO Othe DT B-NPfuture NN I-NPdirection NN I-NPof IN Othe DT B-NPcompany NN I-NP, , O'' '' Oa DT B-NPspokeswoman NN I-NPsaid VBD O. . OMr. NNP B-NPPercival NNP I-NPdeclined VBD Oto TO Ocomment VB O. . OIn IN Oa DT B-NPstatement NN I-NP, , OUS PRP B-NPFacilities NNPS I-NPsaid VBD OMr. NNP B-NPPercival NNP I-NP's POS B-NPemployment NN I-NPcontract NN I-NPcalls VBZ Ofor IN Ohim PRP B-NPto TO Oact VB Oas IN Oa DT B-NPconsultant NN I-NPto TO Othe DT B-NPcompany NN I-NPfor IN Otwo CD B-NPyears NNS I-NP. . OHe PRP B-NPwill MD Oalso RB Oremain VB Oa DT B-NPdirector NN I-NP, , OUS PRP B-NPFacilities NNPS I-NPsaid VBD O, , Obut CC Owo MD On't RB Oserve VB Oon IN Oany DT B-NPboard NN I-NPcommittees NNS I-NP. . OMr. NNP B-NPPercival NNP I-NPwill MD Obe VB Osucceeded VBN Oon IN Oan DT B-NPinterim JJ I-NPbasis NN I-NPby IN OGeorge NNP B-NPKadonada NNP I-NP, , OUS PRP B-NPFacilities NNPS I-NPchairman NN I-NPand CC I-NPpresident NN I-NP. . OIn IN Othe DT B-NPsame JJ I-NPstatement NN I-NP, , OUS PRP B-NPFacilities NNPS I-NPalso RB Osaid VBD Oit PRP B-NPhad VBD Obought VBN Oback RB O112,000 CD B-NPof IN Oits PRP$ B-NPcommon JJ I-NPshares NNS I-NPin IN Oa DT B-NPprivate JJ I-NPtransaction NN I-NP. . OTerms NNS B-NPwere VBD On't RB Odisclosed VBN O. . OThe DT B-NPbuy-back NN I-NPrepresents VBZ Oabout IN B-NP3 CD I-NP% NN I-NPof IN Othe DT B-NPcompany NN I-NP's POS B-NPshares NNS I-NP, , Obased VBN Oon IN Othe DT B-NP3.7 CD I-NPmillion CD I-NPshares NNS I-NPoutstanding JJ Oas IN Oof IN OSept. NNP B-NP30 CD I-NP. . OIn IN Onational JJ B-NPover-the-counter JJ I-NPtrading NN I-NPyesterday NN B-NP, , OUS PRP B-NPFacilities NNPS I-NPclosed VBD Oat IN O$ $ B-NP3.625 CD I-NP, , Ounchanged JJ O. . OThree CD B-NPleading VBG I-NPdrug NN I-NPcompanies NNS I-NPreported VBD Orobust JJ B-NPthird-quarter JJ I-NPearnings NNS I-NP, , Obolstered VBN Oby IN Ostrong JJ B-NPsales NNS I-NPof IN Onewer JJR B-NP, , I-NPbig-selling JJ I-NPprescriptions NNS I-NPdrugs NNS I-NPthat WDT B-NPprovide VBP Ohefty JJ B-NPprofit NN I-NPmargins NNS I-NP. . OMerck NNP B-NP& CC I-NPCo. NNP I-NPreported VBD Oa DT B-NP25 CD I-NP% NN I-NPincrease NN I-NPin IN Oearnings NNS B-NP; : OWarner-Lambert NNP B-NPCo. NNP I-NP's POS B-NPprofit NN I-NProse VBD O22 CD B-NP% NN I-NPand CC OEli NNP B-NPLilly NNP I-NP& CC I-NPCo. NNP I-NP's POS B-NPnet JJ I-NPincome NN I-NProse VBD O24 CD B-NP% NN I-NP. . OThe DT B-NPresults NNS I-NPwere VBD Oin IN Oline NN B-NPwith IN Oanalysts NNS B-NP' POS B-NPexpectations NNS I-NP. . OMerck NNP B-NP& CC I-NPCo NNP I-NP. . OMerck NNP B-NP, , ORahway NNP B-NP, , ON.J. NNP B-NP, , Ocontinued VBD Oto TO Olead VB Othe DT B-NPindustry NN I-NPwith IN Oa DT B-NPstrong JJ I-NPsales NNS I-NPperformance NN I-NPin IN Othe DT B-NPhuman NN I-NPand CC I-NPanimal NN I-NPhealth-products NNS I-NPsegment VBP I-NP. . OA DT B-NPstronger JJR I-NPU.S. NNP I-NPdollar NN I-NPreduced VBD Othird-quarter JJ B-NPand CC I-NPfirst-nine-month JJ I-NPsales NNS I-NPgrowth NN I-NP2 CD B-NP% NN I-NPand CC I-NP3 CD I-NP% NN I-NP, , Orespectively RB O. . OInternational JJ B-NPsales NNS I-NPaccounted VBD Ofor IN O47 CD B-NP% NN I-NPof IN Ototal JJ B-NPcompany NN I-NPsales NNS I-NPfor IN Othe DT B-NPnine CD I-NPmonths NNS I-NP, , Ocompared VBN Owith IN O50 CD B-NP% NN I-NPa DT B-NPyear NN I-NPearlier RBR O. . OSales NNS B-NPfor IN Othe DT B-NPquarter NN I-NProse VBD Oto TO O$ $ B-NP1.63 CD I-NPbillion CD I-NPfrom IN O$ $ B-NP1.47 CD I-NPbillion CD I-NP. . OMevacor NNP B-NP, , OMerck NNP B-NP's POS B-NPnew JJ I-NPcholesterol-lowering JJ I-NPdrug NN I-NP, , Ohad VBD Ohigher JJR B-NPsales NNS I-NPthan IN Oany DT B-NPother JJ I-NPprescription NN I-NPmedicine NN I-NPhas VBZ Oever RB Oachieved VBN Oin IN Othe DT B-NPU.S. NNP I-NPin IN Othe DT B-NPyear NN I-NPfollowing VBG Ointroduction NN B-NP, , Othe DT B-NPcompany NN I-NPsaid VBD O. . OThe DT B-NPdrug NN I-NPwas VBD Ointroduced VBN Oin IN OWest NNP B-NPGermany NNP I-NPthis DT B-NPyear NN I-NP. . OIntense JJ B-NPcompetition NN I-NP, , Ohowever RB O, , Oled VBN Oto TO Ounit NN B-NPsales NNS I-NPdeclines NNS I-NPfor IN Oa DT B-NPgroup NN I-NPof IN OMerck NNP B-NP's POS B-NPestablished VBN I-NPhuman NN I-NPand CC I-NPanimal-health NN I-NPproducts NNS I-NP, , Oincluding VBG OAldomet NNP B-NPand CC I-NPIndocin NNP I-NP. . OIn IN ONew NNP B-NPYork NNP I-NPStock NNP I-NPExchange NNP I-NPcomposite JJ I-NPtrading NN I-NPyesterday NN B-NP, , OMerck NNP B-NPshares NNS I-NPclosed VBD Oat IN O$ $ B-NP75.25 CD I-NP, , Oup IN O50 CD B-NPcents NNS I-NP. . OWarner-Lambert NNP B-NPCo NNP I-NP. . OWarner-Lambert NNP B-NP, , OMorris NNP B-NPPlains NNP I-NP, , ON.J. NNP B-NP, , Oreported VBD Osales NNS B-NPthat WDT B-NPwere VBD Oa DT B-NPrecord NN I-NPfor IN Oany DT B-NPquarter NN I-NPand CC Othe DT B-NPeighth JJ I-NPquarter NN I-NPin IN Oa DT B-NProw NN I-NPof IN O20 CD B-NP% NN I-NPor CC I-NPmore RBR I-NPper-share JJ I-NPearnings NNS I-NPgrowth NN I-NP. . OSpurred VBN Oby IN Ogrowth NN B-NPin IN Oworld-wide JJ B-NPsales NNS I-NPof IN Othe DT B-NPcompany NN I-NP's POS B-NPprescription NN I-NPdrugs NNS I-NP, , OWarner-Lambert NNP B-NPsaid VBD O1989 CD B-NPwill MD Obe VB Othe DT B-NPbest JJS I-NPyear NN I-NPin IN Oits PRP$ B-NPhistory NN I-NP, , Owith IN Oper-share JJ B-NPearnings NNS I-NPexpected VBN Oto TO Oincrease VB Omore JJR B-NPthan IN I-NP20 CD I-NP% NN I-NPto TO Oabout RB B-NP$ $ I-NP6.10 CD I-NP. . OSales NNS B-NPfor IN Othe DT B-NPquarter NN I-NProse VBD Oto TO O$ $ B-NP1.11 CD I-NPbillion CD I-NPfrom IN O$ $ B-NP1.03 CD I-NPbillion CD I-NP. . OPrescription-drug NN B-NPworld-wide JJ I-NPsales NNS I-NProse VBD O9 CD B-NP% NN I-NPin IN Othe DT B-NPquarter NN I-NPto TO O$ $ B-NP340 CD I-NPmillion CD I-NP; : OU.S. NNP B-NPsales NNS I-NProse VBD O15 CD B-NP% NN I-NP. . OThe DT B-NPsegment NN I-NP's POS B-NPgrowth NN I-NPwas VBD Oled VBN Oby IN Osales NNS B-NPof IN Othe DT B-NPcardiovascular JJ I-NPdrugs NNS I-NPLopid NNP B-NP, , Oa DT B-NPlipid NN I-NPregulator NN I-NP, , Oand CC ODilzem NNP B-NP, , Oa DT B-NPcalcium NN I-NPchannel NN I-NPblocker NN I-NP. . OWorld-wide JJ B-NPsales NNS I-NPof IN OWarner-Lambert NNP B-NP's POS B-NPnon-prescription JJ I-NPhealth-care NN I-NPproducts NNS I-NP, , Osuch JJ Oas IN OHalls NNP B-NPcough NN I-NPtablets NNS I-NP, , ORolaids NNP B-NPantacid NN I-NP, , Oand CC OLubriderm NNP B-NPskin NN I-NPlotion NN I-NP, , Oincreased VBN O3 CD B-NP% NN I-NPto TO O$ $ B-NP362 CD I-NPmillion CD I-NPin IN Othe DT B-NPthird JJ I-NPquarter NN I-NP; : OU.S. NNP B-NPsales NNS I-NProse VBD O5 NN B-NP% NN I-NP. . OConfectionery JJ B-NPproducts NNS I-NPsales NNS I-NPalso RB Ohad VBD Ostrong JJ B-NPgrowth NN I-NPin IN Othe DT B-NPquarter NN I-NP. . OWorld-wide JJ B-NPsales NNS I-NPof IN OTrident NNP B-NPgum NN I-NP, , OCerts NNP B-NPbreath NN I-NPmints NNS I-NP, , Oand CC OClorets NNP B-NPgum NN I-NPand CC I-NPbreath NN I-NPmints NNS I-NP, , Oincreased VBN O12 CD B-NP% NN I-NPto TO O$ $ B-NP277 CD I-NPmillion CD I-NP. . OWarner-Lambert NNP B-NPshares NNS I-NPclosed VBD Oat IN O$ $ B-NP109.50 CD I-NPa DT B-NPshare NN I-NP, , Oup IN O$ $ B-NP1.50 CD I-NP, , Oin IN OBig NNP B-NPBoard NNP I-NPcomposite JJ I-NPtrading NN I-NPyesterday NN B-NP. . OEli NNP B-NPLilly NNP I-NP& CC I-NPCo NNP I-NP. . OLilly NNP B-NPattributed VBD Orecord NN B-NPthird-quarter JJ I-NPand CC I-NPnine-month JJ I-NPresults NNS I-NPto TO Oworld-wide JJ B-NPgains NNS I-NPfor IN Opharmaceuticals NNS B-NP, , Omedical JJ B-NPinstruments NNS I-NPand CC Oplant-science NN B-NPproducts NNS I-NPdespite IN Opoor JJ B-NPexchange NN I-NPrates NNS I-NPfor IN Othe DT B-NPdollar NN I-NPthat WDT B-NPslowed VBD Osales NNS B-NPabroad RB O. . OEarnings NNS B-NPcontinued VBD Oto TO Opace VB Osales NNS B-NPbecause IN Oof IN Oa DT B-NPlower JJR I-NPtax NN I-NPrate NN I-NP, , Oprofit NN B-NPfrom IN Othe DT B-NPrenegotiation NN I-NPof IN Othe DT B-NPdebt NN I-NPinstrument NN I-NPreceived VBD Ofrom IN OFaberge NNP B-NPInc. NNP I-NPin IN Oconnection NN B-NPwith IN OLilly NNP B-NP's POS B-NPsale NN I-NPof IN OElizabeth NNP B-NPArden NNP I-NPInc. NNP I-NPin IN O1987 CD B-NP, , Oand CC Onet JJ B-NPproceeds NNS I-NPfrom IN Othe DT B-NPsettlement NN I-NPof IN Opatent NN B-NPlitigation NN I-NPat IN OLilly NNP B-NP's POS B-NPHybritech NNP I-NPInc. NNP I-NPunit NN I-NP. . OThird-quarter JJ B-NPsales NNS I-NPof IN Othe DT B-NPIndianapolis NNP I-NP, , I-NPInd. NNP I-NP, , I-NPcompany NN I-NProse VBD O11 CD B-NP% NN I-NPto TO O$ $ B-NP1.045 CD I-NPbillion CD I-NPfrom IN O$ $ B-NP940.6 CD I-NPmillion CD I-NP. . ONine-month JJ B-NPsales NNS I-NPgrew VBD O12 CD B-NP% NN I-NPto TO O$ $ B-NP3.39 CD I-NPbillion CD I-NPfrom IN O$ $ B-NP3.03 CD I-NPbillion CD I-NPa DT B-NPyear NN I-NPearlier RBR O. . OSales NNS B-NPof IN OProzac NNP B-NP, , Oan DT B-NPanti-depressant NN I-NP, , Oled VBN Odrug-sales NNS B-NPincreases NNS I-NP. . OHigher JJR B-NPsales NNS I-NPof IN Opesticides NNS B-NPand CC Oother JJ B-NPplant-science NN I-NPproducts NNS I-NPmore JJR Othan IN Ooffset VB Oa DT B-NPslight JJ I-NPdecline NN I-NPin IN Othe DT B-NPsales NNS I-NPof IN Oanimal-health NN B-NPproducts NNS I-NPto TO Ofuel VB Othe DT B-NPincrease NN I-NPin IN Oworld-wide JJ B-NPagricultural JJ I-NPproduct NN I-NPsales NNS I-NP, , OLilly NNP B-NPsaid VBD O. . OAdvanced NNP B-NPCardiovascular NNP I-NPSystems NNP I-NPInc. NNP I-NPand CC OCardiac NNP B-NPPacemakers NNPS I-NPInc. NNP I-NPunits NNS I-NPled VBD Ogrowth NN B-NPin IN Othe DT B-NPmedical-instrument JJ I-NPsystems NNS I-NPdivision NN I-NP. . OLilly NNP B-NPshares NNS I-NPclosed VBD Oyesterday NN B-NPin IN Ocomposite JJ B-NPtrading NN I-NPon IN Othe DT B-NPBig NNP I-NPBoard NNP I-NPat IN O$ $ B-NP62.25 CD I-NP, , Odown RB O12.5 CD B-NPcents NNS I-NP. . OReuben NNP B-NPMark NNP I-NP, , Ochairman NN B-NPof IN OColgate-Palmolive NNP B-NPCo. NNP I-NP, , Osaid VBD Ohe PRP B-NPis VBZ O`` `` Ocomfortable JJ O'' '' Owith IN Oanalysts NNS B-NP' POS B-NPestimates NNS I-NPthat IN Othird-quarter JJ B-NPearnings NNS I-NProse VBD Oto TO Obetween IN B-NP95 CD I-NPcents NNS I-NPand CC I-NP$ $ I-NP1.05 CD I-NPa DT B-NPshare NN I-NP. . O⌨️ 快捷键说明
复制代码
Ctrl + C
搜索代码
Ctrl + F
全屏模式
F11
切换主题
Ctrl + Shift + D
显示快捷键
?
增大字号
Ctrl + =
减小字号
Ctrl + -